VSIG4 and glioblastoma: In addition, it has been recently reported that VSIG4 overexpression promoted the epithelial-mesenchymal transition (EMT), invasion and migration of U87-MG glioblastoma cells, which hinted the probability that targeting VSIG4 could inhibit EMT [11].